Acute Myelomonocytic Leukemia - 190 Studies Found
Terminated |
: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Active, not recruiting |
: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome :
: |
Active, not recruiting |
: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Active, not recruiting |
: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay :
|
Active, not recruiting |
: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML :
|
Active, not recruiting |
: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia :
: |
Withdrawn |
: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Completed |
: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes :
|
Active, not recruiting |
: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia :
: |
Completed |
: Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
: |